VANCOUVER, British Columbia, May 28, 2018 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the Community-Based Healthcare market, is pleased to announce that it has placed an order for 27,500 blood glucose + blood pressure monitoring devices to address the hardware availability issues recently faced by its iUGO Care customers.
“Over the last several months our customers in Texas have been unable to secure the monitoring devices they have selected for their patients due to extremely high demand for the units,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Since our clients are not able to onboard patients to our platform without the hardware, we felt that deploying some of our capital to secure the devices necessary to meet the demand from our current contracts was a very worthwhile investment. Placing a large order like this allowed us to negotiate pricing that will generate new profits for Reliq through the sale of this hardware to our customers, while still reducing our clients’ total purchasing costs.”
“We see our relationship with our customers as a true partnership,” said Giancarlo De Lio, Chief Customer Experience Officer at Reliq Health. “We are committed to doing everything we can as a company to ensure our clients’ success. Their reaction to our decision to step up and secure a supply of these devices to meet their needs has been extremely positive. We look forward to helping our clients continue to deliver high quality care in the home to chronic disease patients in underserved communities.”
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq's powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Investor Relations at Reliq Health at 604-566-9233 or IR@reliqhealth.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
